Ignite Creation Date:
2025-12-25 @ 4:38 AM
Ignite Modification Date:
2026-03-05 @ 11:31 AM
Study NCT ID:
NCT02792218
Status:
COMPLETED
Last Update Posted:
2021-10-01
First Post:
2016-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-02
First Submit QC Date:
None
Study First Post Date:
2016-06-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-18
Results First Submit QC Date:
None
Results First Post Date:
2020-10-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-10-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-09-03
Last Update Post Date:
2021-10-01
Last Update Post Date Type:
ACTUAL